SRC-3 Inhibition Blocks Tumor Growth of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant and lethal disease with few treatment options. Steroid receptor coactivator-3 (SRC-3, also known as NCOA3, AIB1, pCIP, ACTR, RAC3, TRAM1) sits at the nexus of many growth signaling pathways and has been pursued as a therapeutic target for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Lett
Autores principales: Song, Xianzhou, Chen, Hui, Zhang, Chengwei, Yu, Yang, Chen, Zhongyuan, Liang, Han, Van Buren, George, McElhany, Amy L., Fisher, William E., Lonard, David M., O’Malley, Bert W., Wang, Jin
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6311429/
https://ncbi.nlm.nih.gov/pubmed/30423406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.11.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares